Country Clinical Trial Manager — End-to-End Lead

Bristol Myers Squibb; Madrid; On-site; EUR 70,000 - 110,000; Full time

Job summary

Bristol Myers Squibb is seeking a Clinical Trial Manager to oversee end-to-end study operations at country level in Spain. You will liaise with global teams, drive feasibility, start-up, recruitment targets and regulatory readiness to ensure on-time delivery.

The role requires extensive experience in cross-functional teams, strong knowledge of GCP/ICH, and proficiency with CTMS and EDC tools. Occasional local travel and a flexible, collaborative environment are expected.

Qualifications

• Bachelor's or master's degree required. Field of life sciences or equivalent.
• Minimum of 4 years' industry related experience.
• Senior Clinical Trial Manager – at least 6 years of industry-related experience.
• Experience in leading cross-functional teams or as part of cross-functional initiatives.
• SME in therapeutic area, systems or processes across department.

Responsibilities

• Acts as the country lead for end-to-end study operational oversight.
• Manages feasibility, country targets, and validation with country leadership.
• Plans timelines and activities for start-up with GTAC and study team.
• Coordinates country-level patient recruitment strategy and timelines.
• Leads risk mitigation, issue resolution and escalation.

Skills

Cross-functional collaboration

GCP/ICH Knowledge

Organizational skills

Communication skills

Education

Bachelor's or Master's degree in life sciences

Tools

CTMS

EDC

Microsoft Office

Job description

Bristol Myers Squibb is seeking a Clinical Trial Manager to oversee end-to-end study operations at country level in Spain. You will liaise with global teams, drive feasibility, start-up, recruitment targets and regulatory readiness to ensure on-time delivery.

The role requires extensive experience in cross-functional teams, strong knowledge of GCP/ICH, and proficiency with CTMS and EDC tools. Occasional local travel and a flexible, collaborative environment are expected.